NDC 0135-0184 Tums Chewy Bites Berry Shake

Tums Chewy Bites Berry Shake with NDC 0135-0184 is a a human over the counter drug product labeled by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The generic name of Tums Chewy Bites Berry Shake is calcium carbonate. The product's dosage form is tablet, chewable and is administered via oral form. The RxNorm Crosswalk for this NDC code indicates multiple RxCUI concepts are associated to this product: 1044532 and 308915.

Dosage Form: Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.

Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

Tums Chewy Bites Berry Shake Active Ingredient(s)

What is the Active Ingredient(s) List?
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.

• CALCIUM CARBONATE 750 mg/1

Inactive Ingredient(s)

About the Inactive Ingredient(s)
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

• ACACIA (UNII: 5C5403N26O)
• ALCOHOL (UNII: 3K9958V90M)
• AMMONIA (UNII: 5138Q19F1X)
• YELLOW WAX (UNII: 2ZA36H0S2V)
• CARMINIC ACID (UNII: CID8Z8N95N)
• CARNAUBA WAX (UNII: R12CBM0EIZ)
• CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
• COCONUT OIL (UNII: Q9L0O73W7L)
• STARCH, CORN (UNII: O8232NY3SJ)
• CORN SYRUP (UNII: 9G5L16BK6N)
• ICODEXTRIN (UNII: 2NX48Z0A9G)
• ETHYL ACETATE (UNII: 76845O8NMZ)
• FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
• ALUMINUM OXIDE (UNII: LMI26O6933)
• FD&C BLUE NO. 2 (UNII: L06K8R7DQK)
• FD&C RED NO. 40 (UNII: WZB9127XOA)
• FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
• ISOPROPYL ALCOHOL (UNII: ND2M416302)
• MALTODEXTRIN (UNII: 7CVR7L4A2D)
• METHYLPARABEN (UNII: A2I8C7HI9T)
• BUTYL ALCOHOL (UNII: 8PJ61P6TS3)
• PHOSPHORIC ACID (UNII: E4GA8884NN)
• PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
• PROPYLPARABEN (UNII: Z8IX2SC1OH)
• WATER (UNII: 059QF0KO0R)
• SHELLAC (UNII: 46N107B71O)
• SORBIC ACID (UNII: X045WJ989B)
• SORBITOL (UNII: 506T60A25R)
• SOYBEAN OIL (UNII: 241ATL177A)
• LECITHIN, SOYBEAN (UNII: 1DI56QDM62)
• SUCROSE (UNII: C151H8M554)
• TERT-BUTYLHYDROQUINONE (UNII: C12674942B)
• TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
• CORN OIL (UNII: 8470G57WFM)

Administration Route(s)

What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.

• Oral - Administration to or by way of the mouth.

Product Labeler Information

What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: Glaxosmithkline Consumer Healthcare Holdings (us) Llc
Labeler Code: 0135
FDA Application Number: part331 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Marketing Category: OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Start Marketing Date: 03-05-2021 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
Listing Expiration Date: 12-31-2022 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.
Exclude Flag: N - NO What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".

* Please review the disclaimer below.